ライブラリ登録: Guest
Begell Digital Portal Begellデジタルライブラリー 電子書籍 ジャーナル 参考文献と会報 リサーチ集
Critical Reviews™ in Oncogenesis
SJR: 0.631 SNIP: 0.503 CiteScore™: 2

ISSN 印刷: 0893-9675
ISSN オンライン: 2162-6448

Critical Reviews™ in Oncogenesis

DOI: 10.1615/CritRevOncog.v5.i4.40
pages 389-428

Tissue-Specific Transformation by Oncogenic Mutants of Epidermal Growth Factor Receptor

T. H. Carter
William K. Warren Medical Research Institute, Department of Medicine, University of Oklahoma Health Sciences Center, P. O. Box 26901, Oklahoma City, OK 73190
H. J. Kung
Department of Molecular Biology and Microbiology, Case Western Reserve University, School of Medicine, Cleveland, OH 44106-4960

要約

Mutations in the receptor for the epidermal growth factor provide valuable insight into mechanisms of growth control. Oncogenic mutants of this receptor tyrosine kinase cause erythroid leukemia, fibrosarcoma, angiosarcoma, glioblastoma, and melanoma. Mutations in the avian protooncogene occur by retroviral mechanisms. Deletion of the ligand-binding domain results in erythroblastosis, while additional mutations in cytoplasmic structures broaden the disease potential to other cell types. A carboxyl-terminal structure of erbB oncogenes modulates growth responses in a complex, cell-specific manner; this tissue-specificity region appears to promote growth in erythroblasts and to produce trans-dominant inhibition in fibroblasts. Human glioblastoma multiforme frequently contains receptor mutations that are reminiscent of avian oncogenes. In hereditary melanoma of Xiphophorus, aberrant regulation of transcription by a recombinant promoter determines tissue-specific tumorigenesis. The diversity of oncogenic mutations raises important questions concerning the roles of several receptor structures. The extracellular domain inhibits the receptor when unoccupied by ligand, for example, through a mechanism that is unknown. The auto-phosphorylation sites are dispensable for transformation, so their function in neoplastic growth is unclear. The carboxyl-terminal region promotes or blocks transformation in different tissues, suggesting complex regulation by unknown cellular factors. These issues are critical to understanding of the mechanisms of receptor activation and tissue tropism for this family of oncogenes.


Articles with similar content:

The Regulation and Regulatory Activities of Alternative Splicing of the SMN Gene
Critical Reviews™ in Eukaryotic Gene Expression, Vol.14, 2004, issue 4
Natalia N. Singh, Elliot J. Androphy, Ravindra N. Singh
Regulation of Epithelial Cell Proliferation, Differentiation, and Plasticity by Grainyhead-Like 2 During Oral Carcinogenesis
Critical Reviews™ in Oncogenesis, Vol.23, 2018, issue 3-4
Mo K. Kang, Wei Chen, No-Hee Park
Specification of Chromatin Domains and Regulation of Replication and Transcription During Development
Critical Reviews™ in Eukaryotic Gene Expression, Vol.10, 2000, issue 1
Yegor S. Vassetzky, Marcel Mechali, Jean-Marc Lemaitre
CREB-Mediated Transcriptional Control
Critical Reviews™ in Eukaryotic Gene Expression, Vol.9, 1999, issue 1
Ourania M. Andrisani
Posttranslational Regulation of p53 Tumor Suppressor Protein Function
Critical Reviews™ in Oncogenesis, Vol.5, 1994, issue 1
Steve A. Maxwell, Jack A. Roth